Image shows Cold agglutinin disease (CAD) – a rare autoimmune hemolytic anemia driven by the production of cold agglutinins (CA). Despite published guidelines, there remains variability in the use and ordering of CA studies. Screening first for a C3d-positive DAT could help significantly reduce the need for more labor-intensive, specialized tests.
Keywords: 3D, Editorial, Biotechnology, Cell biology / Histology, Endocrinology / Metabolic, General Medicine, Vascular Surgery
© Linda Nye